FÜR RISIKOBEWERTUNG BUNDESINSTITUT. MRLs for Biocides Establishment of an EU-wide Procedure

Similar documents
FÜR RISIKOBEWERTUNG MRLs for Biocides Establishment of an EU-wide Procedure

Summary Report of the European Conference on MRL Setting for Biocides

Veterinary Medicines Legislation and Maximum Residue Limits in the EU

Current activities of the European Commission in the area of pesticide residues

Import tolerances in the European Union Can Import Tolerances be set for active substances impacted by the EU hazard-based criteria?

Authorisation procedure for plant protection products. Description of the procedure for applications for zonal authorisations in Germany

Core member of a Biocidal Products Committee Working Group

BUNDESINSTITUT FÜR RISIKOBEWERTUNG

Austria: Experiences with the Zonal evaluation procedure Applying Regulation (EC) No.1107/2009

PLANT PROTECTION DIRECTORATE. Department for Plant Protection (PPP`s) and Plant Nutrition Products (PNP`s) MUTUAL RECOGNITION

Pharmacovigilance- Content of the New EU Legislation and Challenges for BfArM

STANDING COMMITTEE ON THE FOOD CHAIN AND ANIMAL HEALTH SECTION ON GENETICALLY MODIFIED FOOD AND FEED AND ENVIRONMENTAL RISK

Mandate, objectives and rules of procedure for the CVMP Ad Hoc Expert Group on Veterinary Novel Therapies (ADVENT)

EUROPEAN COMMISSION DIRECTORATE-GENERAL FOR HEALTH AND FOOD SAFETY COMMISSION GUIDANCE DOCUMENT 1

Regulatory framework for seed treatments in the EU

Draft agreed by Environmental Risk Assessment Working Party (ERAWP) 31 May Adopted by CVMP for release for consultation 12 July 2012

10041/16 ADD 1 GSC/lt 1 DG B 2B

EU Food Law. protect public health (human, animal and plant);

Guidance on applications for technical equivalence

CMD(h) GUIDANCE FOR MAHs ON THE PHARMACOVIGILANCE SYSTEM AND RISK MANAGEMENT PLAN IN THE MUTUAL RECOGNITION & DECENTRALISED PROCEDURES

COMMISSION IMPLEMENTING REGULATION (EU) /... of XXX

Functioning of the PRAC

Umsetzung des Review 2004 Auswirkungen auf das Europäische Zulassungssystem insbesondere auf das dezentrale und das MR-Verfahren

Progress Report on the Implementation of PPPs Regulations in Republic of Croatia CEUREG FORUM XVIII MEETING

Adoption by CHMP for release for 3-month public consultation 18 November End of consultation (deadline for comments) 28 February 2011

Procedure and experience in Germany

The Federal Institute of Risk Assessment at a glance dates, facts and background

GUIDANCE DOCUMENT ON WORK-SHARING IN THE NORTHERN ZONE IN THE AUTHORISA- TION OF PLANT PROTECTION PRODUCTS

Reflection paper on risk mitigation measures related to the environmental risk assessment of veterinary medicinal products

COUNCIL DIRECTIVE of 15 July 1991 concerning the placing of plant protection products on the market (91/414/EEC) (OJ L 230, , p.

Zulassung von Biozid-Produkten

Guidance on the Biocidal Products Regulation

Pesticide Regulation System in Japan

QUESTIONS AND ANSWERS ON MRP & DCP AND EU ENLARGEMENT

Guideline on good pharmacovigilance practices (GVP)

Recent Developments in Community Residue Control Legislation

FOR RISK ASSESSMENT FEDERAL INSTITUTE. Has the nature of risks changed? New challenges for regulatory authorities" Reiner Wittkowski

Update from the Commission: latest developments in the biocides field

Directive (EU) 2015/412 Allowing Member States to restrict or prohibit the cultivation of GMOs in their territory

DISCOVER OUR SEGMENT REGULATORY SCIENCE

Seminar on «EU Plant Health

ECHA policy for prevention of conflicts of interest

Monthly statistics report: December 2017

European Biocidal Products Forum A.I.S.E. & EBPF SURVEY BPR IMPACT ON BIOCIDAL PRODUCTS AND INNOVATION

(Acts whose publication is obligatory) DIRECTIVE 98/8/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL. of 16 February 1998

BPR update: Union Authorisation, Families and Same Biocidal Product

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

Guidance on the application of mutual recognition in Norway

This document is meant purely as a documentation tool and the institutions do not assume any liability for its contents

Dr. Eva Lechtenberg-Auffarth The Biocide Directive as a new chance for the Protection of Workers

EUROPE S BIOCIDAL PRODUCTS DIRECTIVE: BENEFITS AND COSTS IN URBAN PEST MANAGEMENT

Technical Notes for Guidance on. Dossier Preparation including preparation and evaluation of study summaries

Final Minutes of the Biocides Technical Meeting TM II 08 in Arona, June 2008

DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT

The European Medicines Agency: a model of patient/consumer interaction

Submission of comments on 'Reflection paper on the use of extrapolation in the development of medicines for paediatrics' (EMA/199678/2016)

Adoption by CVMP for release for consultation 11 November End of consultation (deadline for comments) 31 May 2010

Ozone as active substance under the Biocidal Products Regulation

A Global Reference in Laboratory Testing. Laboratory excellence to support your testing of biocidal products, detergents and biopesticides

Bromuconazole 167 g/l + Tebuconazole 107 g/l EC (SOLEIL) Page 1 of 20. REGISTRATION REPORT Part A. Risk Management

Background paper. Food safety in the EU

Feedback from ECHA on dossier and substance evaluation

Introductory cover note to the List of European Union reference dates and frequency of submission of Periodic Safety Update Reports

FACTS. Federal Office for Safety in Health Care

The European Agency for the Evaluation of Medicinal Products Work Programme 2003

Explanatory note on general fees payable to the European Medicines Agency

REGISTRATION REPORT Part A. Risk Management. Product code: A16148C Product name(s): VIBRANCE Active Substance(s): Sedaxane, 500g/L

Guideline on good pharmacovigilance practices (GVP)

Guideline on good pharmacovigilance practices (GVP)

VICH Topic GL32 STUDIES TO EVALUATE THE SAFETY OF RESIDUES OF VETERINARY DRUGS IN HUMAN FOOD: DEVELOPMENTAL TOXICITY TESTING

Risk assessment: the bees (including a personal point of view from a private beekeeper)

EUROPEAN COMMISSION ENTERPRISE DIRECTORATE-GENERAL QUESTIONS. and ANSWERS

Guideline on good pharmacovigilance practices (GVP)

Guideline on the implementation of. European Regulation (EC) 1272/2008

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex. The Rules Governing Medicinal Products in the European Union

INTRODUCTION OF FEES TO BE CHARGED BY THE EMA FOR PHARMACOVIGILANCE

Vacancy Notice. 1. The job (7)

Safety Measures in the new Pharmacovigilance System

Variation Regulations (EU)

Quality & Safety GLP. 44 q&more 02/14

PLANNING FOR REACH 2018 AS A NON-EU COMPANY

Pesticide residues in food - Monitoring programs in Europe

Elemental impurities Expectations for APIs and Excipients in the EU

Polgar ACRO Registration of Pesticides in Russia and Ukraine: Applicants feedback

Variations AGES MEA-LCM-QUAL. Mag. Caroline Kleber. Meet the Case Manager Vienna,

Mid term review of EU Ombudsman's verdict regarding DG SANTE's pesticide decision-taking methods.

MEDICATED FEEDINGSTUFFS AND SPECIFIED FEED ADDITIVES REGULATION AND APPROVAL OF MANUFACTURERS

Review of requirements for immunological medicinal products and their evolution since the start of Community legislation on medicines

Module 1: Administrative information Application form

REACH REGULATION: the new management of chemicals in Europe and operational tools. R egistration. E valuation. A Ch. uthorisation.

A regulatory update in a day for Small to Medium-sized Enterprises

A GUIDELINE ON DOSSIER REQUIREMENTS FOR TYPE I VARIATIONS November 1999

26/04/2016. Guidelines for emergency situations in plant protection

Interface between REACH and CAD:

(EFSA-Q ) 1 For the purpose of this document foods of animal origin are limited to fresh unprocessed products of animal origin.

EudraVigilance Veterinary

The GMO Imperative. Dr. Eva Claudia Lang Austrian Federal Ministry of Health, Dep. II/B/15. Protecting an Promoting Real Food -Conference

Implementation of toxicological data from other legal provisions (e.g. REACH) An industry perspective

Experience of Post approval change management protocol in EU. Mats Welin Senior expert Medical Products Agency Uppsala, Sweden

Clinical Trials application process, legislation & guidelines

Transcription:

BUNDESINSTITUT FÜR RISIKOBEWERTUNG MRLs for Biocides Establishment of an EU-wide Procedure Isabel Günther Federal Institute for Risk Assessment, Berlin, Germany Biocides 2013, Vienna

Introduction Certain uses of biocides can lead to residues in food, e.g. - Disinfectants in the food industry or in homes (PT 4) - Disinfectants incorporated into food contact materials (PT 4) - Insecticides in the food industry, in homes or in animal housing (PT 18) - Products for veterinary hygiene (PT 3) - In-can preservatives, e.g. in dishwashing detergents (PT 6) When residues in food occur, MRLs must be set. For biocides, an EU-wide procedure for setting MRLs has yet to be established. Several unresolved issues regarding such a procedure have been identified and will be explained in this presentation.

Regulatory Framework for Biocide MRLs MRL setting is required by Regulation (EU) No 528/2012 - Art. 19(1)(e) where appropriate Applications in animal husbandry - EMA: Reg. (EC) No 470/2009 (veterinary medicinal products) All other biocidal applications - EFSA: Reg. (EC) No 396/2005 (pesticide residues) - Reg. (EEC) No 315/93 (food contaminants) - Reg. (EC) No 1935/2004 (food contact materials) - Dir. 2002/32/EC (undesirable substances in animal feed)

Regulatory Framework for Biocide MRLs Points to consider: Unclear which use falls under which legal framework. So far only defined for Reg. (EC) No 470/2009. Guidance needed For dual-/triple-use active substances, two or more sets of MRLs are set, which may have different values and which may not account for residues from the other uses. Effective communication necessary within EFSA and between EFSA and EMA to avoid this situation

Regulatory Framework for Biocide MRLs Points to consider: The MRL-setting procedures under the respective legal frameworks differ from each other: - Some involve national MS authorities, others only EU authority (EFSA), EMA appoints experts - Submission formats for application and dossier - Data requirements - Assessment concepts

Differences between Regulatory Frameworks Place of submission: 470/2009: MRL application submitted to EMA; evaluation by EMA-appointed rapporteur from CVMP (not member state) with help from experts 396/2005: MRL application submitted to MS; evaluation by MS and then by EFSA 1935/2004: SML application submitted to MS; evaluation by EFSA The other legal frameworks: evaluation by EFSA How can it be ensured that applicants know where to submit? Will guidance be made available?

Differences between Regulatory Frameworks Formats: Each framework uses different submission formats for application and dossier What formats will be used for biocide MRL applications? -Will existing formats be amended to include biocides? -Will a new format for biocides be created and apply across legal frameworks?

Differences between Regulatory Frameworks Assessment concepts: Toxicological reference values Plant protection products ADI and ARfD Veterinary drugs ADI (based on chronic and acute endpoints) Residue intake Chronic and acute Chronic only Consumption data National consumption data from EU member states Daily food basket (based on arbitrarily fixed high values ) All other biocidal applications? Biocidal applications in animal husbandry MRLs checked against different exposures and reference values

Differences between Regulatory Frameworks Other open questions: An MRL evaluation concept is so far only available for uses in animal husbandry (Reg. (EU) No 470/2009). Reg. (EU) No 470/2009 has been amended to include biocides. Reg. (EC) No 396/2005 is currently being amended to include biocides. Will the other legal texts be amended as well?

Coordination of MRL Evaluations MRL applications with same active substance submitted by many different companies and often in more than one Member State. AS a BP x (AP x) BP y (AP y) BP z (AP z) MRLs for AS a Effective co-ordination necessary! - Which authority? - Which database: R4BP? EFSA Extranet?

Timeframe for MRL Setting for Biocides Four scenarios: 1. MRL application is submitted prior to BP application (shortly after active substance approval) 2. MRL and product applications are submitted at the same time 3.MRL application submitted after BP application (necessity for MRLs seen seen during BP BP evaluation) 4. MRL application submitted after BP application (necessity for MRLs seen during mutual recognition)

Safe use MRL Timeframe for MRL Setting for Biocides Art. 19(1)(e): A biocidal product shall be authorised provided the following conditions are met: where appropriate, maximum residue limits have been established MRLs must be set before a biocidal product can be authorised. Authorising MS EMA / EFSA DRA finds MRLs needed MRL setting Authorisation 1 year

Timeframe for MRL Setting for Biocides Experience with plant protection products and veterinary medicinal products shows that it takes at least 1 year to evaluate MRL application and set MRLs. Not possible to set MRLs in time for BP authorisation no authorisation BP has to be taken off market Transition rules may be needed (e.g. temporary marketing permission without MRLs; establishment of temporary high MRLs based only on rough health assessment)

Timeframe for MRL Setting for Biocides Proposal: It would be most effective to set MRLs after collecting all possible uses of an active substance and set MRLs for the most critical use. Advantage: One MRL evaluation rather than several (with each BP application) Disadvantage: Information only available after BPs have been assessed during national authorisation. Transition rules needed.

MRL Workshop in March 2014 Many open questions! To discuss these open questions and propose solutions, the German Federal Institute for Risk Assessment with support of COM is organising a workshop. When: March 2014 (probably 18th-19th) Programme: Presentations on the existing procedures, working groups for discussion and development of recommendations on specific open questions Content: Topics to be discussed are currently being developed by a preparations committee

BUNDESINSTITUT FÜR RISIKOBEWERTUNG Thank you for your attention! Isabel Günther Federal Institute for Risk Assessment Max-Dohrn-Str. 8-10 D-10589 Berlin Isabel.Guenther@bfr.bund.de www.bfr.bund.de